Document is current
Any future updates will be listed below
-
Authors
Weber, Nicholas D. https://orcid.org/0000-0002-3584-644X
Odriozola, Leticia
Martínez-García, Javier https://orcid.org/0000-0002-2289-1719
Ferrer, Veronica https://orcid.org/0000-0002-7687-6151
Douar, Anne https://orcid.org/0000-0002-3744-8445
Bénichou, Bernard https://orcid.org/0000-0002-9331-0926
González-Aseguinolaza, Gloria
Smerdou, Cristian https://orcid.org/0000-0002-6861-6579
-
Funding
Funding for this research was provided by:
Vivet Therapeutics.
- License Information
-
More Information
Article History
Received: 21 December 2018
Accepted: 18 November 2019
First Online: 13 December 2019
Competing interests
: Drs. Weber, Ferrer, Douar, Bénichou, and González-Aseguinolaza are all employees of Vivet Therapeutics, a startup biopharmaceutical company developing gene therapy approaches for treatment of rare metabolic diseases. All other authors declare no competing interests.
